Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9092727 | 0.80 | ADRB2 (0.46) | AOC3TDP1TSHR | |
| SCHEMBL705505 | 0.78 | HTR2A (0.46) | TAAR1HTR2AHRH1TDP1TSHR | |
| SCHEMBL3482033 | 0.77 | TAAR1 (0.52) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL11651391 | 0.77 | TAAR1 (0.52) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL29403357 | 0.76 | TAAR1 (0.50) | TAAR1AOC3TRPA1RIPK1HTR2A | |
| SCHEMBL5266627 | 0.76 | TAAR1 (0.50) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL2736711 | 0.73 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1HTR2A | |
| SCHEMBL6583604 | 0.73 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1HTR2A | |
| SCHEMBL9092685 | 0.72 | ADRB2 (0.43) | AOC3TDP1TSHRKDM4EALDH1A1 | |
| SCHEMBL6280516 | 0.72 | RIPK1 (0.67) | TAAR1AOC3TRPA1RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2128897-B1 | SILICON DIELECTRIC TREATING AGENT FOR USE AFTER ETCHING, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJITSU LTD (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8716209-B2 | Agent for post-etch treatment of silicon dielectric film, method of manufacturing semiconductor device, and semiconductor device | FUJITSU LIMITED (JP) | 2014-05-06 | — | — | US | disclosed |
| US-20100007031-A1 | AGENT FOR POST-ETCH TREATMENT OF SILICON DIELECTRIC FILM, METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJITSU LIMITED (JP) | 2010-01-14 | — | — | US | disclosed |
| EP-2128897-A1 | SILICON DIELECTRIC TREATING AGENT FOR USE AFTER ETCHING, PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | Fujitsu Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-7427692-B2 | Process for preparation of 7-[α-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | LUPIN LTD. (US) | 2008-09-23 | — | — | US | disclosed |
| US-7230097-B2 | Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | LUPIN LTD. (IN) | 2007-06-12 | — | — | US | disclosed |
| US-20060149096-A1 | Process for preparation of 7-[a-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | LUPIN LTD. (IN) | 2006-07-06 | — | — | US | disclosed |
| US-20050113570-A1 | Process for preparation of 7-[alpha-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | LUPIN LTD. (IN) | 2005-05-26 | — | — | US | disclosed |
| US-4504657-A | Cephadroxil monohydrate | BRISTOL-MYERS COMPANY (US) | 1985-03-12 | — | — | US | disclosed |
| US-RE31730-E | Process for the preparation of the crystalline monohydrate of 7-(D-α-aα-(p-hydroxyphenyl)acetamido)-3-methyl-3-cephem-4-carboxylic acid | BRISTOL-MYERS COMPANY (US) | 1984-11-13 | — | — | US | disclosed |
| US-4291160-A | 7-(1,3-Dithiolan-2-imino)-Δ2 -cephalosporanic acid derivatives | RICHARDSON-MERRELL INC. (US) | 1981-09-22 | — | — | US | disclosed |
| US-4234721-A | Process for the preparation of the crystalline monohydrate of 7-[D-amino-(p-hydroxyphenyl]acetamido)-3-methyl-3-cephen-4-carboxylic acid | BRISTOL-MYERS COMPANY (US) | 1980-11-18 | — | — | US | disclosed |
| US-4208516-A | 7-(1,3-Dithiolan-2-imino)-Δ2 -cephalosporanic acid derivatives | RICHARDSON-MERRELL INC. (US) | 1980-06-17 | — | — | US | disclosed |
| US-4206305-A | FROM S-ALKYLATED SALT OF 1,3-DITHIOLANE-2-THIONE AND A 7-AMINOCEPHALOSPORANIC ACID, BACTERICIDES | RICHARDSON-MERRELL INC. (US) | 1980-06-03 | — | — | US | disclosed |
| US-4206119-A | ANTIBIOTICS, BACTERICIDES | RICHARDSON-MERRELL INC. (US) | 1980-06-03 | — | — | US | disclosed |
| US-4160863-A | ANTIBIOTIC | BRISTOL-MYERS COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
| US-4066657-A | ANTIBACTERIAL AGENTS FOR ANIMAL FEED SUPPLEMENTS | PFIZER INC. (US) | 1978-01-03 | — | — | US | disclosed |
| US-4036846-A | ANTIBACTERIAL | PFIZER INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4031077-A | Antibacterial 3-phosphono penams | PFIZER INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-3994939-A | BACTERICIDES | PFIZER INC. (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113570-A1 | Process for preparation of 7-[alpha-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | IGLV6-57, APC, HBZ | TAAR1 4529/4885AOC3 1292/4885TRPA1 4753/4885 |
| US-20060149096-A1 | Process for preparation of 7-[a-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid | IGLV6-57, APC, IL2 | TAAR1 4517/4885AOC3 1393/4885TRPA1 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.